ReviewPharmacy (Basel, Switzerland)2022

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine.

Michael Migotsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.